Add-on Acquisition • Life Science

Ignyta Acquires Actagene Oncology

On May 20, 2013, Ignyta acquired life science company Actagene Oncology

Acquisition Context

This is Ignyta’s 1st transaction in the Life Science sector.
This is Ignyta’s 1st transaction in the United States.
This is Ignyta’s 1st transaction in California.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	May 20, 2013
Target	Actagene Oncology
Sector	Life Science
Buyer(s)	Ignyta
Deal Type	Add-on Acquisition

Target Company

Actagene Oncology

San Diego, California, United States

Actagene Oncology, Inc. develops personalized medicines for high unmet need cancer indications, based on cancer genome mining and sequencing.

Explore More Deals

Browse All 215,158 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Ignyta

San Diego, California, United States

Category	Company
Founded	2011
Sector	Life Science
Employees	115

DESCRIPTION

Ignyta, Inc. is a trailblazing biotechnology company catalyzing personalized medicine with integrated Rx/Dx solutions for cancer and immunology. Ignyta was founded in 2011 and is based in San Diego, California.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
State: California	1 of 1
Country: United States	1 of 1
Year: 2013	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - California M&A - United States M&A - 2013 M&A